Trending Now

2505 Articles Available

1 3

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market

View from the Top: Cell and Gene Therapy Successes and Promise

Green Energy Is Almost Here: A CDMO’s Approach to Sustainability

Is this Pharma’s Best Kept Secret? Partnering with Australian Companies for Pharmaceutical Development and Manufacturing

Maximizing Resources and Potential for Success by Failing Fast

Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future

Addressing Swallowing and Palatability Issues with Patient-Friendly Dosage Forms

Who is Using FAIR Data in Life Sciences R&D Today?

Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

Leveraging Biopharma Sensor Technologies for Cultivated Meat Processes

Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market

Embracing FAIR Data on the Path to AI-Readiness

Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies

Reach the Patient Quicker with GBI’s Manufacturing Solutions

Innovating DCTs Through Application and Cross-Functional Delivery

Innovations in Baculovirus–Insect Cell Expression Systems

Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles

Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement

100 Years Young: How Science, Collaboration, and Innovation are Driving Corning’s Future

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Viscosity Reduction with An Excipient Platform and Feasibility Testing Service

Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

On the Journey to Support Drug Developers With End-to-End Outsourcing

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos

Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies

CytoDyn Takes Steps towards a Brighter Future

Building on Experience and Investing in an Integrated mRNA Offering

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Using Artificial Intelligence to Get the Right Drug to the Right Patient at the Right Time

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

Supporting Drug Development – Increasing Probability of Success

Collaboration is Key to the Development of Effective Bioprocess Analysis Solutions to Address Complex Data Needs

Early Reports of Positive Experiences with EMA’s New Clinical Trials Information System

Managing Risk in Cutting-Edge mRNA Therapeutics

On the Journey to a New Industry Standard for E. coli-based Protein Production

Optimizing Plasmid Production to Meet Growing Demand

Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control

Expanding Point-of-Care and CME Support for Clinicians

Investing in Innovation with Global Solution Centers

Accelerating Drug Development with AI-Enabled 3D Spatial Biology

Roundtable: How is an increased focus on patient-centric concerns influencing the way that you work?

Roundtable: The State of AI and ML in Pharma and Biopharma

Enhanced Solubility through API Processing: Salt and Cocrystal Formation

Real-World Data and Artificial Intelligence are Transforming Clinical Development

Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures

Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat

Enhance Patient Engagement in Decentralized Trials with Home Healthcare Solutions

Addressing Cancer Therapy Resistance by Targeting Translational Regulation

Does Your Biologics CDMO Truly Have a Culture of Quality?

Integrating Digital Solutions to Streamline Biopharma Operations

Bringing Mass Spectrometry out of the Lab and to the Point of Need

Stopping Bleeds and Saving Lives

Synthetic Biology: A Potential Game-Changer for the Biopharma Industry

Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery

A Novel Technology Platform for Bone Regeneration and Cancer Treatment

Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions

Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology

The Right Materials for Success in Bioprinting

Digital Therapeutics and the Song of the Future of Healthcare

Bedside Cell Therapies: Point-of-Care Manufacturing Is Slowly Becoming a Reality

Accelerating Oncology Clinical Trials with Deep Digitalization of Patient Data

The Exciting Potential of Inhalation Vaccines

The Opportunities and Challenges Posed by Biosimilar Interchangeability

Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells

The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More

Redefining Innovation and Growth in Pharmaceutical Distribution

An Introduction to HPAPIs and Cytotoxic Drugs

Cosmeceuticals Are Here. When Will Regulations Catch Up?

Enabling Seamless Workflows for Small Molecule Drug Discovery

Biologics Outsourcing: Decision Drivers and Key Considerations

Lipid Technology for Delivery of Gene-Editing Therapies

Decentralized Clinical Trials: the Future is Now

Aqueous Critical Cleaning for Pharma and Biopharma Applications (Companion to Aqueous Cleaning Handbook)

Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence

Helping Clinicians Make Better Decisions More Easily

Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development

Targeted Protein Degradation Provides Promising Alternative to Address Unmet Medical Needs

Investing in the Future of mRNA Manufacturing

Overcoming Bottlenecks in mRNA Manufacturing

Scale-Up Expertise to Support Your Biologics Life Cycle

Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy

A Strategic Approach to Pre-License Inspections

Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down

Lipid Nanoparticles: Transforming the Nanomedicines Market

Risk-Based Optimization of Viral Vector Processes Adds Real Value

An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market

From Llamas to Yeast: Producing Functional Therapeutic Antibody Fragments in Saccharomyces cerevisiae

Reducing the Challenges Sites Face when Implementing Decentralized Trials

Interest in Decentralized Trials Rising in Asia-Pacific

The Expanding Role for Recombinant Proteins in Research

Rapid Supply of Anti-Idiotype Antibodies Facilitates Preclinical and Clinical Antibody-Based Drug Development

Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing

Revisiting Comparative Drug Development

Innovating to Optimize Quality in Injectable Drugs

Three Benefits of Using In Silico Technologies for Drug Discovery

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies

Sustainability in Pharmaceutical Manufacturing: A CDMO’s Contribution

High-Intensity Sweeteners for Taste Optimization

Optimizing Transient Transfection for Viral Vector Production

Optimized Multispecific Antibody Design, Development, and Manufacturing

Formulating Flexibility with ActiMask® Taste Masking

Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms

Addressing Poor API Solubility with Comprehensive Particle Engineering Technology

New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!

Advancing Extrusion-Based 3D Printing for Drug Production

Applying an Advanced Pharma 4.0 Perspective to Design the Facility of the Future

Quality in Equals Quality Out in mRNA Manufacturing

How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More

Leveraging Experience to Reduce Timelines for IND-Enabling Activities

Closing the Gender Gap in Clinical Research

Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making

Vaccines Present a Novel Strategy for Opioid Overdose Prevention

Rare Disease Patients Benefit from Clinical Trial Flexibility

State of the Cell and Gene Therapy Market

Examining the Potential of Precision/Personalized Medicine

Reimagining the Pharmaceutical Supply Chain

Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers

Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing

Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand

Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties

Overcoming Limitations with Transient Protein Expression to Accelerate Development

Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants

How All Clinical Trial Stakeholders Can Collaborate as One Study Team

Antibiotic Resistance: Advances in Understanding and Drug Development

Evolving Solutions to Optimize Clinical Trial Decentralization

Accelerating ADC Development with Advanced Payload Intermediates

Integrating Cell Line and CMC Development

Asymchem: Leading with Technology

Five Ways to Embed Truly Diverse and Inclusive Patient Engagement into Pharma’s DNA

Beyond Drug Sales: Adding Value with Digital Health

Life Science Industrials Are Key to the Growth of the Biopharma Industry

Theranostic Manufacturing Solutions

A Guide on Comprehensive Decontamination Solutions for the Pharmaceutical Industry

New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes

Supporting Biodefense Countermeasures with Strong Capabilities and Expertise

Reducing Time to IND, Increasing Quality, and Building Trust through Shared Data

Creating a More Resilient Pharmaceutical Supply Chain One Segment at a Time

Assuring Excipient Quality for Parenteral Products

IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?

Closing the Developability Gap for RNA Therapeutics and Vaccines with a Fit-for-Purpose Analysis Kit

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Taking Adoptive Cell Therapies to the Next Level

Improving the Therapeutic Index of ADCs with a Peptide Linker Technology

Regulatory Considerations for Lipid Excipients

Cloud Control: Maintaining Compliance as Regulated Apps Move Off Premise

Accelerating Oncology Clinical Research Remotely

Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains

Mental Health During a Global Pandemic

Small Molecule API Market Trends

Duplicated Document and Data Creation Must Stop!

The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative

CAR-T Study Shines New Spotlight on Clinical Trials Representation

Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management

Digital Frontiers: What NFTs Can Do for Pharma

Aseptic Isolators with Integrated Decontamination Technology Accelerate Cell Therapy Development

10 More Biotechs Making Moves in 2022

Creating Agility in Clinical Research with Remote Monitoring

Contamination Control Strategies for the Manufacture of Conventional and Next-Generation Biologics

Optimizing Fed-Batch Processes with Chemically Defined Media and Feeds

Transferring 3D Printing into Pharma: The Journey Has Begun

Guide to Resource Recovery for Fortune 500 Companies

Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support

Staying Agile to Bring Therapies to Patients with Rare Diseases

Driving Further Innovation by Integrating a Decentralized R&D Network

Crafting a Successful Partnership with a Contract Research Organization

Meeting the Needs of the Evolving Sterile Injectables Market

Gaining Insights into the Challenges, Trends, and Needs of Animal Health Organizations

Minimizing Patient Burden in Cell and Gene Therapy Trials

New Clinical Frontiers in Neuroscience

A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research

Tuning the Myeloid Compartment with a Best-in-Class CDMO

Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner

Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing

Transformative Early and Patient-Centric Treatments for Retinal Diseases

NFTs Are Bringing the Regenerative Medicine Community Together

Tackling Liver Disease with a Multimodal Cyclophilin Inhibitor

Changing the Future of Cell Culture and Accelerating Next-Generation Therapies

The Intersection of mRNA Biology and Artificial Intelligence is Yielding Unique mRNA Drug Candidates

7 Reasons Specialty Chemical Manufacturers Are Embracing Used Chemical Equipment

A PODular Therapies-as-a-Service Approach To Fundamentally Change the CAR-T Cell Therapy Landscape

CAPA Management is Worth Doing, and Worth Doing Well

Adding Dimensionality to Data Mapping for Higher-Level Analysis

The Bioanalytical Development Journey

Addressing Regulatory Challenges for Ophthalmic Combination Products

A Next-Generation Baker’s Yeast Biofoundry Presents Transformative Potential for Biomanufacturing

Translating Three Decades of Experience in Plasmid DNA Into Customer Success

New Polymer-Lipid Delivery System for mRNA

Data-Based Regulatory Submissions: What DADI Means for You

Olon Announces the Creation of a Major Center of Research and Development in Italy, That Will Give Rise to an Innovative Global R&D Model

Olon Invests in New Spray Dryer at Rodano R&D Centre

Bringing Novel Solutions to Market for Unmet Needs

Approaching Viral Vector Manufacturing With an Emphasis on Quality and Design

Increasing Safety, Efficacy, and Global Equity with Intranasal Vaccines

A Media Platform for Cost-Effective and Scalable 2D and 3D Bioreactor MSC Expansion

Unique Manufacturing Challenges Associated with Sterile Eye Ointments

Advancing Visual Inspection of Printed Pharmaceutical Materials

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

Fighting Cancer by Focusing on Nuclear Export

Digitalizing Quality Management: What the Food Industry Can Teach Pharma

The Smart Approach to Preclinical Development for Bacterially Expressed Biologics

Unique Vector Expression Technologies for Boosting Protein Production in E. coli

New Drug Watch: Alzheimer Drug Still Controversial

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?

Designing More Effective Therapeutic Proteins Using an Integrated Laboratory and Computational Platform

Developing a Novel Anti-Inflammatory for Patients with Severe Asthma

Better Bioprocessing Efficiency Through Centralized Orchestration

Global Investment Trends and Getting Noticed by PE/VC Firms

Streamlining Process Validation for Drug Substance Manufacturing

Pharmaceutical Supply Chain Challenges & Opportunities Survey Report

Will Remote Pharma GMP Auditing Continue Post-COVID?

Used Cannabis Processing Equipment—The 5 Trends Increasing Demand

Quality Plant-Made mAbs with FastPharming®

Best Practices For Oncolytic Virus Design, Development, and Manufacturing

Overcoming Analytical Challenges for Gene Therapies

Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects

Changing the Paradigm of Cancer Drug Discovery and Development with Plants

The Global Immunization Disparity

The Limitless Potential of Thin Film Freezing

Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

An Evolving Biologics Landscape and Driving Innovation and Opportunity

Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing

Innovating Cleanroom Systems Through Integrated Technology

Developing New Antibody Therapeutics for COVID-19 and Beyond

Filling Industry Gaps and Driving Innovation with Life Science Industrials

Altis Biosystems Awards New Research Funding to Armed Forces Radiobiology Research Institute

Facilitating Clinical Manufacturing of Recombinant Proteins with Large-Scale Single-Use Fermentation Technology

TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, United Kingdom

Enabling the Commercialization of Microbiome Live Biotherapeutic Products with Fit-for-Purpose Cryopreservatives

A Small Biotech with Two Complex Bispecific Antibody Candidates Benefits from Lonza’s Blend of Expertise and Flexibility

PPD’s Approach to Practical Translational Medicine

Improving the Handling and Safety of Pharmaceutical Raw Materials through Dry Granulation

Growing Life Science and Biotech in Montana

A CDMO Dedicated to Supporting Small-Volume, Small-Molecule Parenteral Projects

Enabling Stable, High-Viscosity Injectable Drug Products with New Excipient Combinations

Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market

The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances

Serving an Accelerated Market with mRNA Production

Designing More Sustainable Small Molecule API Manufacturing Processes

Expanding the Philadelphia Cell and Gene Therapy Hub

Staying Ahead of Trends in Small-Volume Parenteral Manufacturing

Incorporating Patient Voices from the Start of Drug Development

Meeting the Renewed Demand for Microbial Protein Production

2021 Roundup: The Year of Cell and Gene Therapy

The Potential of Life Science Industrials

Presenting an Integrated Solution for mRNA Vaccine Manufacturing

Focusing on Flexibility in Facility Design

Cell and Gene Therapies’ Evolving Temperature-Controlled Requirements Call for Specialized Logistics Solutions

Leveraging Partnerships and a Unique History to Address Supply Chain and Capacity Challenges in Gene Therapy Manufacturing

Streamlining OSD Operations from Tableting through Serialization

Coping with a Talent Shortage and Talent War in Cell and Gene Therapy

Advancing Pharma and Medical Device Development with Novel Biomaterials

Discussing the Advancements in Oncology

Bringing 3D Organoid Models Into a High-Throughput Environment

IDT Biologika Celebrates 100 Years of Successful Vaccine Development and U.S. Expansion

Remaining Nimble in Biopharma Construction and Engineering

Moving Beyond the Industrialization of MSCs

Boosting Cell Densities and Productivity with Tailored Media in Seed Train

Investing in mRNA Production

Viral Vectors, Vaccines — A New Era Of Collaborative Design

ABC: Analytics for Biomanufacturing and Clinical Trials of Biomanufactured Products

Lean and Client-Focused: The Future of Life Sciences Engineering and Architecture

Shortening Biopharmaceutical Process Development Timelines with High-Throughput Approaches.

Pandemic Playbook for Gene Therapy Manufacturing

How Can Oncology Trials Be Decentralized?

Expanding the Cell and Gene Therapy Ecosystem in Philadelphia

Listening to Clients and Expanding Across the Clinical Supply Chain

Exploring Innovation and the Vast Potential of Transdermal Patch Drug Delivery

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001

Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis

It’s All Here – Talent. Research. Results.

Limiting Risk In mRNA Development and Production

Evaluating Single-Use Technologies for Biomanufacturing

Integrating a Personal Approach to Clinical Supply Services

Collaborating Strategically and Leveraging Innovation to Drive Success

Accelerating Biologics Development with High-Quality Protein Stabilization Excipients

An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility

Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing

A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

Reshoring a Nation’s API and Pharmaceutical Production

Estimands in Oncology Trials

Integrating a Fragmented mRNA Supply Chain

Solving the Patient-Centric Formulation Riddle

Streamline HME Projects with Early Partner Engagement

Inline Solutions to Overcome Inspection Challenges for Parenteral Products

Solving Complex Chemical Problems Across All Phases of NCE Programs

Innovating to Realize the Benefits of Data Sharing

A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs

Complex Early Development Studies — Managing FIH to Phase Ib

Championing In Vitro Biocompatibility/Biological Reactivity Testing for Plastics Used in Pharma Manufacturing

Arranta Bio Announces Completion of Sale of Florida Site and Progress on $150M Investment Plan to Expand Development and Commercial Manufacturing Services

Integrated mRNA Support Facilitates mRNA Product Development and Commercialization

Reducing Project Timelines with Integrated Cleanroom Solutions

Navigating Analytical Requirements for GMP Viral Vectors

Focus on Commercial Parenteral Manufacturing at Evonik

Realizing the Promise of RNA Therapies with Lipid Nanoparticle Delivery

How Blockchain Will Secure the Future of Cannabis Research

Evolution from Basic Distribution to a Comprehensive Biopharma Services Company

Expanding and Serving the Market with Flexible Single-Use Capacity

Critical Cleaning and Detergent Synergy

Supporting Small and Emerging Pharma through Collaboration and Specialized Expertise

The Application of Mannitol In Wet Granulation

Arranta Bio Announces First End-to-End Manufacturing for mRNA Vaccines in its Commercial-Ready GMP Facility

Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations

Streamlining Highly Potent Drug Commercialization

Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status

Delivering the Full Value Chain for Oncology Clinical Trials

For mAbs, a Small Biotech Recognizes the Value in Lonza’s Expertise and Track Record

Early Targeting of Chronic Inflammation That Precedes and Causes Synaptic Loss

Illustrating a Successful Small Biotech-CDMO Relationship

Avara on Client Service and Innovation— We Make It. About You.

Integrating Sourcing, Packaging, Labelling, and Distribution for Efficient Clinical Kitting

Unique Commercial Experience Primes Avid Bioservices for Growth

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Design Considerations for Live Biotherapeutic Product Facilities Working with Spore-Forming Bacteria

Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing

Enabling Gene-Edited hMSCs with a Fit-for-Purpose Transduction Agent

The Future of the Delivery of Quality

Shorten Time to Market with New Data-Driven Lyophilization Process

Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure

A Look at Genetic Vaccine Development and Manufacturing

Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances

Framing the Narrative on CMC Development for Microbiome Therapeutics

6 Analytical Strategies to Consider Before Submitting Your Cell and Gene Therapy Application

Preparing to Face the Next Global Challenge: Studying Post-Acute COVID-19 Syndrome

Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development

Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?

Planning for Success, Addressing Quality Early for Gene Therapies

Utilizing Personalized Analytics and Biosensors in Healthcare

Inspection of BFS Containers–Reaching New Heights of Performance with 13 Cameras

Bridging the Biopharmaceutical Manufacturing Digital Divide

Robust Harvest Clarification for Adeno-Associated Viral Vectors via Depth Filtration

Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies

Understanding the Link Between Gut Health and Disease

Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned

The Advantages of Implementing Plant-Based Vaccines

Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion

TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility

SPI Pharma launches UltraBurst™, the first in class preformulated platform for flash orally dispersible tablets

Quality and Compliance Ensures Business Sustainability for Avara Arecibo Clients

TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas

Rethinking the Global Pharmaceutical Supply Chain Post-COVID-19

Introducing UltraBurst, the Fastest Rapidly Disintegrating Product

Focusing on the Patient Experience in Clinical Trials with Ancillary Kitting Supplies

Digital Therapeutics: Redefining Prescription Medication in the Information Era

Supporting Global Decentralized and Virtual Clinical Trials During Challenging Times and Beyond

Q: How is your organization using social media to extend your marketing efforts? What are your goals, and what has been successful?

German CDMO Richter-Helm Expands Plant to Serve Demand for Biologics Manufacturing

Exploring the Tumor Microenvironment in Cancer Treatment

Erasca Announces Pricing of Upsized Initial Public Offering

Stemson Therapeutics Secures $15M Series A Funding to Cure Hair Loss

Vetter´s New Clinical Manufacturing Site Now Fully Integrated

GSK Unveils Plan for One of Europe’s Largest Life Science Campuses in Stevenage

How Does Avara Pharmaceutical Services Envision the Future of the Pharma/Biopharma Industry?

Lilly Announces Acquisition of Protomer Technologies

Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing

The Essentiality of Transportation to the Pharma Industry

CAR-T Cell and Gene Therapy Market: Challenges and Opportunities

Breakthrough Results for Jardiance® (Empagliflozin) Confirm Emperor-preserved as First and Only Successful Trial for Heart Failure with Preserved Ejection Fraction

ENA Respiratory Begins Phase I Study of COVID-19 Preventative Nasal Spray Designed to Stimulate Body’s Firstline Immune Defense in the Nose

Continuous Inline Viral Inactivation for Next-Generation Bioprocessing

Preparing for the Next Pandemic: The lessons Learned from COVID-19 and Preparing for the Next Outbreak

Training the Immune System to Recognize Cancer Cells

BioVectra's Strategic Brand Update

Yourway's Major Expansion to Support Clinical Trial Needs

AbbVie Exercises Right to Acquire TeneoOne and Lead Asset TNB-383B for the Potential Treatment of Relapsed or Refractory Multiple Myeloma

Working to Overcome Analytical Challenges Posed by Genetic Vaccines

Innovation vs Monetization: The Curative Therapy Conundrum

Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients

Factory of the Future Will be a Convergence of Digital and Bioprocessing Technologies

Avoiding Costly And Time-Consuming Mistakes In Gene Therapy Process Development

Reducing the Risk During Cell and Gene Therapy Development and Manufacturing

Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies

Thermo Fisher Scientific Acquires PPD and Leverages Clinical

Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine

The Power of RepliGut In Vitro Intestinal Stem Cell Models

Simplifying Operations with Ready-to-Use Vials

Genentech Launches Oncology Clinical Trial Diversity Alliance

Olon Announces a New Highly Potent API Expansion in Its Rodano Site

Innovative Approach to Process Development

Cell Therapy Facility Design Synopsis: Horizontal vs. Vertical

Roche Obtains CE Mark for the SARS-CoV-2 Antigen Self Test Nasal Allowing for Rapid Self Testing of COVID-19 At Home

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

Paramit Corporation Announces Acquisition by The Tecan Group

Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™

Biotage Launches New Automated Platform for Plasmid DNA Purification

10 Ways to Improve Your Project Execution

Alconox Inc. Announced Its 75th Anniversary as an Internationally Distributed Manufacturer of Critical Cleaning Detergents

Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra®

An Unnatural Phenomenon: How Synthetic Biology May Disrupt Pharma and Beyond

Exploring Self Care with Unique Cannabis Experiences

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

Controlling the Cost of Ownership with Modular Facility Construction

TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

The Benefits of Expanding OSD Capacity

Considering Leadership in Pharma

Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases

The Future of Innovation Post-Pandemic

Resolving Cannabis Cleaning Challenges

FDA Grants Accelerated Approval for Aduhelm™ as the First and Only Alzheimer’s Disease Treatment to Address a Defining Pathology of the Disease

Alan Jones Returns to CRB as Vice President of Business Development

RheaVita Closes EUR 2.5 million Series A Financing Co-Led by Novalis Biotech Acceleration and PMV

Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization

How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Manufacturing Partnerships

Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies

A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs

Organon Launches as New Global Women’s Health Company

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

How Bioanalysis Supports the Development of New Cell and Gene Therapies

Novartis and Molecular Partners Announce Start of EMPATHY Clinical Trial for Ensovibep for the Treatment of COVID-19

New Fasenra® Data from the Meltemi Extension Trial Confirm Long-term Safety and Efficacy in Severe Eosinophilic Asthma for up to Five Years

Modern Strategies for Dermatology Clinical Trials

Yourway Breaks Ground on Major Expansion At Allentown, PA - Including Phase I Clinical Trials Unit

Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline

Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience

Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform

Thermo Fisher Scientific and UCSF to Open Cell Therapy cGMP Manufacturing and Collaboration Center

Docbot Closes Series A Financing Led by Khosla Ventures and Appoints Andrew J. Ritter as CEO

Vetter Once Again Wins Axia Best Managed Companies Award

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine

Increasing Predictability with AAV Platform Technologies

Disruptive Technologies in Life Sciences: Personalized Medicines

CVS Health Introduces Clinical Trial Services

Challenges of Manufacturing the Expanding Range of Bi/Multispecific Modalities

Evolving Role of the Process Architect

Using Blockchain to Drive Drug Development and Healthcare Data Management

Pfizer and BioNTech to Vaccinate Olympic Athletes in Tokyo

Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site

FDA Emergency Authorization

Pixel by Labcorp COVID-19 PCR Test Home Collection Kit Receives FDA Emergency Authorization for Ages 2-17

PR-M05-21-014

Reflections on a 10-Year Journey in the Microbiome

Anticipating the Next Decade of Gene Therapy

MilliporeSigma Announces VectorY as Winner of its Advance Biotech Grant

ReCor Medical Announces Results from Study Showing Clinically Significant Blood Pressure Reduction

Why the Industry Is Moving Toward Blockchain Technology

Collaboration

BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity

PR-M05-21-013

Big Data in Drug Manufacturing

Appointment

Altis Biosystems Appoints Bill Thelin, Ph.D. Chief Scientific Officer

PR-M05-21-012

German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand

Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial

How Agile Construction Practices Can Help Bring New Drugs and Vaccines to Market

Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform

Aetion Closes $110M Series C Funding Round Led by Warburg Pincus

Advances in the Oral Delivery of Peptides

Creating Value with Tailored ODT Solutions

Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio

Integrated Ancillary Sourcing Services for Clinical Trials

Pfizer and BioNtech Receive First U.S. Authorization for Emergency Use of Covid-19 Vaccine in Adolescents

iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program

Venair Group Breaks Ground on a New Excellence Center for its Bioprocessing Tubing and Single Use Solutions

Remembering the Details: Partnering with an Equipment Supplier During a Merger or Acquisition

Understanding a Dynamic Industry Through Mergers and Acquisitions

Challenges to Process Validation for Viral Vectors

EMA Starts Evaluating Use of COVID-19 Vaccine Comirnaty in Young People Aged 12 to 15

Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance

Life Imitating Science: Arranta Bio’s Commitment to Corporate Social Responsibility and Diversity

Common Challenges and Solutions of Equipment Ownership and Use

Using a Natural Molecular Warning System to Fight Cancer and Infectious Diseases

BioVectra and PhaseBio Discuss Creating an Optimal Partnership

Providing Self Care Experiences With Functional Cannabis

Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine

Moderna Announces Supply Agreement with Gavi for up to 500 Million Doses of COVID-19 Vaccine Moderna for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries

Preparing for COVID-19 Vaccine Distribution Despite Tight Shipping Capacity

Aiding Material Qualification and Risk Assessment for Single-Use Biomanufacturing

Blue Water Acquisition Corporation Announces Merger Agreement with Clarus Therapeutics

HEALED Consortium Successful in a €10.5M DTIF-Supported Program to Develop Groundbreaking New Therapies for Currently Incurable Cancers

Exploring the Natural Pharmacopeia and Incubating a Biotech Company

Preparing for the ADC Explosion with End-to-End Support

Bluebird Bio Provides Update on Severe Genetic Disease Programs and Business Operations

Sanofi to Help Manufacture Moderna's COVID-19 Vaccine

DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA

The Link Between COVID-19 and Immunity

Monopteros Therapeutics Initiates Clinical Trial to Reprogram Regulatory T Cells in Solid Tumors

Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study

Zymergen Announces Pricing of Upsized Initial Public Offering

Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing

Perception is Reality: Integrating Virtual and Augmented Reality Across the Pharmaceutical Discovery and Manufacturing Landscape

Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology

Economically Viable, Same-Day Autologous Cell Therapies

Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse

Versant Ventures Raises $950 Million Across Three Vehicles

NeuroPace, Inc. Announces Pricing of Initial Public Offering

Blockchain: Increasing Efficiency and Transparency Across the Supply Chain

GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology

Novartis to Produce Roche's Actemra/RoActemra

PhysIQ Announces Strategic Collaboration to Scale Digital Medicine

An Economic Update on Natural Health and Cannabis Products during COVID-19

Four Technology Trends Bringing Personalized Medicine to Life

Extensive Experience is Crucial to Speed to the Clinic and Market for Live Biotherapeutic Products

Microsoft Accelerates Industry Cloud Strategy for Healthcare with the Acquisition of Nuance

Restarting a Manufacturing Campus and Revitalizing a Community

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization

FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available Now.

Sanofi Acquires Tidal Therapeutics and Adds an mRNA-Based Research Platform

Managing the Complexities of International Clinical Trials

Sanofi to Invest in Vaccine Production Site in Singapore

LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp

Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers

A CEO’s Perspective: Positioning a CDMO for Significant Growth

How an Agile Company Addressed the Pandemic: Moving from Psychiatric Medicines to a COVID-19 Therapeutic

The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic

Terminal Sterilization for Parenteral Drugs: Finding the Right CDMO Partner

Shaping the Future of Biopharma through Next-Generation Contract Drug Manufacturing

Stainless Steel to Single-Use: How to Adapt to the Changing Landscape In SUT

United Therapeutics Announces FDA Approval and Launch of Tyvaso for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data From the Phase 2 Blaze-4 Trial Evaluating Bamlanivimab With Vir-7831 in Low-risk Adults With Covid-19

Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics

GSK to Support Manufacture of Novavax’ COVID-19 Vaccine

Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?

Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs

BrainScope Launches Next-Gen Medical Device for Concussion Detection

NeuroRx Announces ZYESAMI™ Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19

Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV

Beyond 2020: Looking into the Crystal Ball for Gene Therapy

Better Together: Collaborating to Simplify Complexities in Drug Development

Data-Driven Decision-Making Throughout the Pharma Life Cycle

Transforming the Treatment of Ocular Diseases and Cancer with Peptide Drugs

Therapeutic Potential of Novel Plasma Protein Production Technology

Standardizing Best Practices for Transporting Cell and Gene Therapies

How Is SGD Pharma Evolving its Business Model to Meet the Future of Healthcare?

Successful Drug Development with Synthetic Liposomes: Critical Aspects and Strategies

Accelerating Drug Development with Microphysiological Systems (MPS)

Investing with a Focus on Medical Devices and Digital Health

Organ-on-a-Chip Technology Aims to Disrupt Traditional Drug Testing Models

Overcoming Skin Assay Challenges with Living Human Models

CRISPR RNPs and the Future of Cell and Gene Therapy

The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues

Product Diversification Through Expansion Into the Animal Health Market

Innovation and Flexibility Drive Success During the COVID-19 Pandemic

Protecting Clinical Research and Patients Through Decentralized Trial Strategies

Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, Mass., Manufacturing Facility to Supply Clinical and Commercial Microbiome Products for Clients and Closes Series B Equity Financing

Building an Integrated and Effective CDMO from the Ground Up

Facilitating the Full Spectrum of Decentralized Trials

PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab

Anticipating the Logistics of a COVID-19 Vaccination Effort

Avara Pharmaceutical Services: Specialization with a Client-Centric Approach

How Is FEC Evolving its Business Model to Meet the Future of Healthcare?

Targeting Retinal Diseases with an Ophthalmic Formulation of Bevacizumab

Enabling Pharma Researchers to Think Differently with Effective Data Manipulation

How Does AES Clean Technologies Envision the Future of the Pharma/Biopharma Industry?

Enhancing Drug Delivery with Thin-Film Freezing Technology

How Is Arranta Bio Evolving its Business Model to Meet the Future of Healthcare?

How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?

How Is Dynamk Capital Facing the Future of Healthcare?

Q&A: Meeting the Challenges of the Pandemic through Virtual Trade Shows

How Does Dynamk Capital Envision the Future of the Pharma/Biopharma Industry?

Trends Shaping the Dynamic Market for Parenterals

The Precarious Pharmaceutical Supply Chain: To Reshore or Not to Reshore – Part I

How Does SGD Pharma Envision the Future of the Pharma/Biopharma Industry?

How Does Evolve Envision the Future of the Pharma/Biopharma Industry?

How Is SPI Pharma Evolving its Business Model to Meet the Future of Healthcare?

How Does TriRx Envision the Future of the Pharma/Biopharma Industry?

How Is Globyz Evolving its Business Model to Meet the Future of Healthcare?

Creating Quality Content for Effective Digital Marketing

How Does Arranta Bio Envision the Future of the Pharma/Biopharma Industry?

How Is Sanaclis Evolving its Business Model to Meet the Future of Healthcare?

How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry?

Realizing the Promise of Therapeutics Targeting the Endocannabinoid System

How Is Polpharma Biologics Evolving its Business Model to Meet the Future of Healthcare?

How Does ECRI Envision the Future of the Pharma/Biopharma Industry?

Facing the Challenges of the COVID-19 Pandemic

How Is Avara Pharmaceutical Services Evolving its Business Model to Meet the Future of Healthcare?

How Does Yourway Envision the Future of the Pharma/Biopharma Industry?

Nationalism and the Pharmaceutical Supply Chain

Mobile Research Nursing: Evolving to Meet Pandemic Challenges

How Does SanaClis Envision the Future of the Pharma/Biopharma Industry?

Changing the Paradigm of Stem Cell Technology

How is SanaClis Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

Combating Cancer and Other Diseases with Supercharged T Cells

The Growing Importance of Local Manufacturing and Nearby Outsourcing Partners

Successful Drug Development with Synthetic Liposomes: Critical Aspects and Strategies

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells

How Does Pii Envision the Future of the Pharma/Biopharma Industry?

The Business of a Pandemic: Mergers and Acquisitions During COVID-19

Expanding Laboratory Access to Gene Sequencing

How Does Polpharma Biologics Envision the Future of the Pharma/Biopharma Industry?

How Is Yourway Evolving its Business Model to Meet the Future of Healthcare?

How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?

How Does Federal Equipment Company Envision the Future of the Pharma/Biopharma Industry?

COVID-19 and the Growing Need for Dual-Source Supply Chains

How Is Pii Evolving its Business Model to Meet the Future of Healthcare?

How Is TriRx Pharmaceutical Services Evolving its Business Model to Meet the Future of Healthcare?

Avara Pharmaceutical Services: Achieving Successful OSD Rx-to- OTC Conversions

How Does Globyz Biopharma Services Envision the Future of the Pharma/Biopharma Industry?

Lessons Learned from the Ground Floor of Life Science Advising

Getting Your Biologic to Clinic Faster and More Efficiently

Approved Therapeutics for a Novel Pandemic: Drug Repurposing to Treat COVID-19

How are you rethinking your supply chain and operational fitness in light of the COVID-19 pandemic?

What steps is your company taking to address drug pricing issues?

Leveraging Biosynthesis to Create Pure Cannabinoids for Less

Leveraging Digitally Reported Outcomes in Clinical Trials

Enhancing Human Gut Tissue Models through Gene Editing

Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19

Evaluating Microbiome Therapies with Intestinal Cell Models

Russia's Sputnik V COVID-19 Vaccine Is 91% Effective

Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies

The Bristol Myers Squibb Foundation and National Medical Fellowships Launch $100 Million Program to Help Increase Diversity and Inclusion in Clinical Trials

Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory

AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million

SEQENS Invests in New Technologies

Celltrion to Launch Both Antigen and Antibody Testing Kits in the U.S.

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study

Nereid Therapeutics Raises $50M in Series A Funding

WuXi Advanced Therapies Expands Services to Include High-Quality and Cost-Effective R&D and GMP Plasmid DNA

BIOMEDICAN Announces Successful Biosynthesis and Large-Scale Production of Rare Cannabinoids CBG/CBGA

Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program

Merck to Acquire VelosBio

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study

Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA

Novartis Announces Collaboration with Molecular Partners to Develop Two DARPin Therapies for Potential Use Against COVID-19

NeuroRx and Relief Therapeutics Announce Continuation of RLF-100 Trial for the Treatment of COVID-19 Respiratory Failure

Qualifying ODT Excipient Systems Beyond Disintegration Performance

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences

100% Remission Rate Reported in Third Dose Cohort of Actimab-A CLAG-M Phase 1 Combination Trial in Patients with Relapsed or Refractory AML

Distek’s New ezfill+ Dissolution Media Preparation System Now Offers Data Integrity Support

CureVac Reports Positive Interim Phase 1 Data for its COVID-19 Vaccine Candidate, CVnCoV

Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine

Lilly Announces Agreement with U.S. Government to Supply 300,000 Vials of Investigational Neutralizing Antibody to Fight COVID-19

Intuitive Launches $100 Million Venture Capital Fund

Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screening

M&A

Syneos Health to Acquire Synteract, a Top CRO Provider to Emerging Biopharma

PR-M10-20-20

Bayer Acquires AskBio to Broaden Innovation Base in Cell and Gene Therapy

Retrophin Announces Agreement to Acquire Orphan Technologies

Abzena Invests $60m into cGMP Manufacturing Capacity

Vetter Continues its Long-term Investment Strategy to Sustain Future Growth

Soligenix Announces Phase 3 FLASH Study Continues to Demonstrate Positive Benefits in Patients with Cutaneous T-Cell Lymphoma

Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of an Inhaled Treatment for Self-Administered COVID-19 Therapy

Abbott Receives FDA Emergency Use Authorization for its COVID-19 Blood Test

SPI Pharma Appoints Scott Thomson as CEO

Lilly Statement on the NIAID Decision to Pause Enrollment in ACTIV-3 Clinical Trial

FDA Approves First Treatment for Ebola Virus

COVID-19 Long-Acting AntiBody (LAAB) Combination AZD7442 Rapidly Advances into Phase III Clinical Trials

Avail Medsystems Raises $100 Million in Series B Funding Led by D1 Capital to Meet Demand for Procedural Telemedicine™ Technology for the Operating Room

Centaur Biopharmaceutical Services Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates

Kymanox Adds Top Experts in Human Factors to Enhance Combination Product Capabilities

Georgia State Researchers Developing Tool to Predict Medication Response in Mental Health Patients

Farxiga Granted Breakthrough Therapy Designation in U.S. for Chronic Kidney Disease

Lucid Scientific Secures $3 Million in Series Seed Financing Led by Dynamk Capital

Arranta Bio Announces Mechanical Completion of Commercial-Ready Capacity for Advanced Biologics

SGD Pharma Extends Industry-Leading Ready-to-Use Molded Glass Vial Range with Introduction of EasyLyo and ISO20mm 50ml Sizes in Tray

ILiAD Biotechnologies Reports Positive Topline Results from Phase 2b Trial for Pertussis Vaccine Candidate BPZE1

Celyad Oncology Announces Clinical Trial Collaboration to Evaluate CYAD-101 with KEYTRUDA

How is Pii Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

Preventative Nasal Spray Shown to Reduce Viral Replication by up to 96% in COVID-19 Challenge Study

Avara Liscate: High Standards and Expertise in Sterile Manufacturing

Positioning a CDMO to Meet Future Needs

Rethinking Pharma’s Responsibilities in a Time of Crisis

How is Federal Equipment Company Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

RefleXion and Sofinnova Partners Recognized with Salus Excellence Award at the Convergence in Oncology Summit

Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury for COVID-19

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

Regulating Clinical Trials in Pandemic Times

What’s Next for the Supply Chain Post-Pandemic

How is Olon Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021

A Personalized Cell Therapy Chain Management Platform

Evolving Needs for Comprehensive Clinical Comparator Sourcing Strategies

The Power of Digital Transformation

Essentials of an Industry-Leading CDMO Partner for Highly Potent Projects

Innovative Biomaterials Facilitate Novel Medical Devices

How is Globyz Biopharma Services Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

The Scripps Research Institute to Pay $10 Million to Settle False Claims Act Allegations Related to Mischarging NIH-Sponsored Research Grants

Olive Adds $106MM to Transform Healthcare Payments with AI Workforce

Alaxia Breaks New Ground With Lead Compound ALX‑009 as Virucidal Agent

Driving More Effective Medicine by Listening to Patients

COVID-19: Understanding the Virus, the Pandemic, and the Path Forward

Exploring the Future of Healthcare in 25 Countries in 25 Days

COVID-19 and Europe: Driving Nationalism Rather than Solidarity

Investing at the Intersection of Industrial Manufacturing and Healthcare

How is SGD Pharma Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

REYVOW Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase Study

Genentech’s Phase III EMPACTA Study Showed Actemra Reduced the Likelihood of Needing Mechanical Ventilation in Hospitalized Patients With COVID-19 Associated Pneumonia

SGD Pharma Introduces Ensiemo, the New Complete Child-Resistant Packaging Solution for CBD Oils

In Conversation: Novel Off-the-Shelf Targeted Cell Therapies

Epigenetic Regulation to Treat Acute Organ Injury and Chronic Liver Diseases

Developing Transformative Treatments for Rare Endocrine Diseases

Leveraging the Cell Cytoskeleton for the Treatment of Cancer and Neurodegenerative Diseases

Applying a Synthetic Approach to the Development of a New Generation of Antibiotics

Seqens CDMO North America Appoints Jean-Noel David as Managing Director

Paradigm4 Launches Reveal Single Cell App for Analyzing Large Scale Data Sets

Novigenix Presents New Immuno-Transcriptomic Data for Prediction of Response to Immunotherapy in Metastatic Urothelial Cancer Patients

Leveraging the Native Immune Response to Fight Cancer

Applying the Principles of Immunotherapy to Infectious Diseases

Solving Unmet Clinical Needs by Harnessing the Science of Aging

Gilead Sciences to Acquire Immunomedics

Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs

Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine

Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India

Computational Discoveries for Clinical Development of Novel Cancer Therapies

Redesigning Organisms as Metabolism Architects

A Therapeutic Strategy for Neurological Disorders

Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life

MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion

Pfizer and BioNTech Announce Data from Preclinical Studies of COVID-19 Vaccine Candidate

Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating Pneumococcal Conjugate Vaccine

Creating Value through Best Practices Across a Global, Integrated Service Provider

Leveraging Innovative Technologies to Access Better Data More Efficiently and Cost-Effectively

Molecules that Changed Medicine

Aseptic Manufacturing with State-of-the-Art Technologies

How is Avara Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

AstraZeneca, Oxford SARS-CoV-2 Vaccine Trials Temporarily Paused

IBM Watson Health and OrbitalRX to Launch Integrated Solution to Assist Hospital Pharmacy Providers in Managing Drug Shortages

GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering

LabCorp Launches First Combined Test for COVID-19, Flu and RSV in Time for Flu Season

Biopharma Leaders Unite to Stand with Science

AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine

AES Releases 3 New Standard Cleanroom Models

CSL to Manufacture and Supply University of Queensland and Oxford University Vaccine Candidates for Australia

How is SPI Pharma Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

Drug Approval Trends: Significant Acceleration in Recent Years

CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research for Further COVID-19 Vaccine Development

AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy

TriRx Pharmaceutical Services Acquires MSD Animal Health Manufacturing Site located in Segre-en Anjou Bleu, France Including Long-term Supply Agreement

SEQENS Inaugurates HPAPI Unit

What is your perspective on how the pharma industry has responded to the COVID-19 pandemic? What lessons have been learned?

What two or three drug molecules do you identify as having had the greatest impact on society? What about on the pharmaceutical industry?

Hackensack Meridian Health Enrolling Individuals for COVID-19 Vaccine Clinical Trial

Luina Bio Announces New Bio-Manufacturing GMP and Development Facility Expansion

FDA Approves First-of-its-Kind Automated Insulin Delivery and Monitoring System for Use in Young Pediatric Patients

How is TriRx Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

Bilim Pharmaceuticals, H&T Presspart and Hovione Technology Unveil Collaboration for New Asthma Product: Ventofor Combi Fix Delivered by PowdAir Plus

Nestle to Acquire Aimmune Therapeutics

Cassiopea Receives FDA Approval for Acne Drug

How is Polpharma Biologics Innovating through the Integration of Advanced Cell Line Development Capabilities to Help Shape the Future of Healthcare?

Regeneron Adds 400 Jobs in Ireland

Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira Immunologics

TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION Therapeutics for COVID-19 Treatment

Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222

Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19

Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand

Cognate Announces the Appointment of Two Independent Board Members

Kohlberg and Mubadala Sign a Definitive Agreement to Acquire Majority Stake in PCI Pharma Services

QIAGEN to Launch Digital SARS-CoV-2 Antibody Test

AstraZeneca Initiates Phase I Clinical Trial Initiated for Monoclonal Antibody Combination for COVID-19

Takeda to Sell OTC Drug Unit to Blackstone for $2.3bn

ROME Therapeutics Appoints Drug Discovery Veteran Dennis Zaller, Ph.D., as Chief Scientific Officer

Dragonfly Therapeutics and Bristol Myers Squibb Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program

Frontida BioPharm, Inc. Announces Highly Potent Compound Contract Manufacturing Suite

FDA Accepts Application for Xolair Prefilled Syringe for Self-Administration Across All Indications

MOBILion Closes $35M Series B Financing Round

Trevena Announces FDA Approval of OLINVYK Injection

FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect COVID-19 Test

Hyperfine Research Receives 510(k) Clearance from US FDA for Market-Ready Swoop Portable MRI System

AeroNabs Promise Powerful, Inhalable Protection Against COVID-19 Inspired by Llamas

Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility

Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19

European Commission Concludes Further Talks to Secure J&J COVID-19 Vaccine

AstraZeneca Ships FLUMIST QUADRIVALENT Vaccine in the U.S. for 2020-2021 Flu Season

RLF-100 Clinical Trial Shows Rapid Recovery from Respiratory Failure Due to Coronavirus

Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate

Bristol Myers Squibb and the Bristol Myers Squibb Foundation Commit $300 Million to Accelerate and Expand Health Equity and Diversity and Inclusion Efforts

Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement

Altis Biosystems Announces Completion of a $3.1 Million Seed Investment Led by VentureSouth

FDA Approves First Liquid Biopsy Next-Generation Sequencing Companion Diagnostic Test

Seres Therapeutics Shares Positive Top Line Results

Neutrolis Announces Development of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) for Patients With Severe COVID-19

Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site

AstraZeneca Signs COVID-19 Vaccine Deal with Chinese Company

SK pharmteco Announces General Manager to SK biotek Ireland

Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine

Premier Research Adds to Diverse Team of Oncology Experts

FDA Approves GSK’s BLENREP for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

PPD Signs New Service Agreement with Pfizer

PMV Pharma Closes $70 Million in Series D Financing

Clinical Ink Announces Its Acquisition by GI Partners

Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 Vaccine

BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo Combination in Melanoma

Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine

AlloVir Announces Pricing of Upsized Initial Public Offering

Vetter Achieves Carbon Dioxide-Neutral Levels

Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin

DFC to Sign Letter of Interest for Investment in Kodak’s Expansion Into Pharmaceuticals

Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for COVID-19 Vaccine

Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe

Moderna Begins Phase 3 COVE Study of mRNA Vaccine Against COVID-19

AstraZeneca and Daiichi Sankyo Enter Collaboration to Develop and Commercialize New Antibody Drug Conjugate

AstraZeneca's Breztri Aerosphere Approved in the US for the Maintenance Treatment of COPD

Novartis Launches First-of-its-Kind Not-for-Profit Portfolio of Medicines for Symptomatic Treatment of COVID-19

BioAegis Therapeutics Receives Approval to Proceed with Phase 2 Trial of its Gelsolin COVID-19 Treatment

New Rapid Molecular Test for Tuberculosis Can Simultaneously Detect Resistance to First- and Second-Line Drugs

Pfizer and BioNTech to Receive $2 Billion from U.S. Government

Common FDA-Approved Drug May Effectively Neutralize Virus That Causes COVID-19

Merck and IRBM Announce Pioneering Collaboration to Advance Peptide Therapeutics

FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing

Pfizer and BioNTech Report T Cell Response in COVID-19 Vaccine

Synairgen Announces Positive Results from Trial of SNG001 in Hospitalized COVID-19 Patients

Integrated Design and Engineering: Focused on the End Goal

AI Startup Deep Longevity Launches With Series A Financing and New AI System to Tackle Aging-related Diseases

Biohaven Recruits Khloe Kardashian for Migraine Campaign

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine with the Imbokodo Study

AstraZeneca's Drug Significantly Reduces the Rate of the Composite of Stroke and Death in Patients

Speeding up ADC Development With the Right Partner Organization

MilliporeSigma Invests $20 Million in New Switzerland Laboratory

Gilead Sciences and Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies

Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers

FDA Prepares for Resumption of Domestic Inspections with New Risk Assessment System

Genome Medical Raises $14 Million to Expand Virtual Clinical Genetics Care and Accelerate Telemedicine Technology Development

Foundational Research Published in Nature Biotechnology Showcases Auxolytic’s Approach to Developing Nutrient-Based Cell Therapy Control Switches

New Data from Phase IIIb Study Reinforces Safety Profile of Roche’s Hemlibra in People with Haemophilia A

Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Patients

Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19

Blackstone Announces $4.6 Billion Final Close of Life Sciences Fund

Haima Therapeutics Receives Phase II TVSF Award from the State of Ohio to Develop its SynthoPlate Product for Veterinary Use

GSK and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Candidate Vaccine

Vetter Further Expands its Development Service with New Site in Austria

Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus and Influenza Vaccines

Drug Prices Increase in July

How is SPI Pharma Preparing to Face the Future of Healthcare?

The Key to Tackling Drug Development Complexity: Collaboration

Novavax Announces $1.6 Billion Funding from Operation Warp Speed

Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate

Regeneron Awarded a $450 Million Contract to Manufacture REGN-COV2

Tesla to Make Molecule Printers for German COVID-19 Vaccine Developer CureVac

Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder

LabCorp Introduces Xcellerate COVID-19 Clinical Study Solution

FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines

Fujifilm Partners with Dr. Reddy's and Global Response Aid for Deployment of a COVID-19 Treatment Drug Outside of Japan

Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2

Humana to Offer LabCorp At-Home COVID-19 Test Collection and Collaborate with Walmart and Quest Diagnostics to Offer Drive-Thru Testing for Humana Members

Leveraging Bioinformatics for Nontraditional Drug Discovery

Small-Scale Screening Technology for Amorphous Solid Dispersion Development

Innovating to Increase Adherence for Colon Cancer Screening

Translating Epigenetic Research into Promising Cancer Therapies

In Conversation: Pressure BioSciences — Putting Pressure on Quality Research, Drug Development, and Cannabis (CBD) Products

INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19

One-time Treatment Generates New Neurons, Eliminates Parkinson's Disease in Mice

Gene Therapy in Mice Builds Muscle, Reduces Fat

Goldfinch Bio Secures $100 Million in Series B Financing

Pharmaceutics Know-How and Service Excellence to Re-Energize a CDMO

A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership

In Conversation: NantKwest — Harnessing Natural Killer Cells to Treat Cancer

Daiichi Sankyo Announces Start of Discussions with AstraZeneca Regarding Supply in Japan of Novel Coronavirus Vaccine

The FDA Confirms Certain COVID-19 Serology and Antibody Tests Should Not Be Used

CLEW Receives FDA Emergency Use Authorization for Its Predictive Analytics Platform in Support of COVID-19 Patients

FDA Approves First-Of-Its-Kind Percep PC Neurostimulator with BrainSense Technology

Simplifying the Supply Chain with Large-Volume Western CDMO Partners

How is TriRx Preparing to Face the Future of Healthcare?

Is the Pharma Industry Developing Cultural Intelligence?

FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials

Piramal Pharma Solutions Announces Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.

Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future

Sygnature Discovery Boosts Senior Management Team With Appointment of Dr. Paul Overton

Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs Through Process Engineering and Technological Innovation

Growing With a Flexible, Collaborative CDMO

How is SGD Pharma Preparing to Face the Future of Healthcare?

What technology do you foresee leading the industry over the coming decade, both in terms of real approvals and general impact?

Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas

INOVIO Receives $71 Million Contract from U.S. Department of Defense to Scale Up Manufacture of COVID-19 DNA Vaccine Delivery Device

Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability

Gilead Sciences Secures Exclusive Option to Acquire Pionyr Immunotherapeutics

Evolution is Essential in the Dynamic Pharmaceutical Industry

A Look Back at The Road To BIO

Building an Entrepreneurial Society in Scotland

Healthcare In the European Union

Visualizing the Future of Contract Development and Manufacturing for Cell and Gene Therapies

Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals

Fulcrum Therapeutics to Evaluate Losmapimod as Potential Treatment for COVID-19

Supernus Completes Acquisition of CNS Portfolio from US WorldMeds

Naari Completes Acquisition of ANDAs From Intas Pharmaceuticals

Proprietary Tracking and Visibility Tools Ensure Secure Transportation

New Mannitol Formulations Are a Gem of a Collection

Leveraging a Biomanufacturing Legacy to Support New Business

Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals

Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV

Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride

Latam Cargo Expands Its Pharma Network to Satisfy Latin American Markets' Demand

Facilitating Pharma Licensing and Partnering

Accelerating Innovation for Gene Therapy

Process Understanding Central to Successful Drug Synthesis

Supporting Customers with an Integrated Fermentation Offering

Low-cost Dexamethasone Reduces Death in Patients with Severe Respiratory Complications of COVID-19

Eli Lilly Drug Significantly Reduces the Risk of Breast Cancer Returning

Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders

FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD

Your Project Is Cancelled: What Do You Do With All That Equipment You Just Ordered?

Facilitating the Commercialization of Disruptive Industrial Life Science Technologies

How is Avara Preparing to Face the Future of Healthcare?

How is SanaClis Preparing to Face the Future of Healthcare?

Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

Calquence Showed Long-Term Efficacy and Tolerability for Patients with Chronic Lymphocytic Leukemia in Two Trials

Vertex Announces New Clinical Data for Investigational Gene-Editing Therapy CTX001 in Severe Hemoglobinopathies

Vaxcyte Announces Pricing of Upsized Initial Public Offering

CDMO Services Designed to Support Evolving Pharma Business Models

Revolutionizing Silica Nanoparticle Drug Delivery

Facilitating Drug Re-Innovation with Artificial Intelligence

FDA Alerts Patients of Amneal and Impax Laboratories Epinephrine Auto-Injector Device Malfunctions

Braeburn Submits Request for Final Approval of BRIXADI for the Treatment of Opioid Use Disorder

FDA Accepts Shionogi’s Supplemental New Drug Application for the Treatment of Ventilator-Associated Bacterial Pneumonia

FDA Clears IND for iNKT Cells to Treat COVID-19 Patients

Legal Issues in Licensing and M&A

How is Pii Preparing to Face the Future of Healthcare?

ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring Assays for Minimal Residual Disease

FDA Reissues Emergency Use Authorizations Revising Which Types of Respirators Can Be Decontaminated for Reuse

SiO2 Materials Science Receives $143 Million Contract from U.S. Government

Alnylam Presents Positive Phase 3 Results from ILLUMINATE-A Study of Lumasiran, an Investigational RNAi Therapeutic for Treatment of Primary Hyperoxaluria Type 1

Customer Engagement and Information Sharing are Essential for Success in Orphan Drug Outsourcing

Applying Chemistry and Engineering Expertise to Continuous Processing

Reducing Fill-Finish Wait Times

Novavax Selects AGC Biologics to Manufacture Matrix-M Adjuvant for Novel COVID-19 Vaccine

Athira Pharma Closes $85 Million Series B Financing

AstraZeneca to Discover and Develop Novel Therapies Targeting RNA-Modifying Proteins in Oncology Collaboration with Accent Therapeutics

Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, as Senior Vice President, Clinical Development

Addressing the Challenges of Comparator Drug Sourcing for Clinical Trials

Polpharma Biologics: Building on Early Achievements

Solving the Industry’s Capacity Utilization Problem

How is Olon Preparing to Face the Future of Healthcare?

FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure

Pfizer Establishes New Program to Support Continued Biotechnology Innovation

Sun Pharma Receives Approval from DCGI to Initiate Clinical Trial with Nafamostat in Covid-19 Patients

Hillhouse Capital Leads $160M Series B Round in Genor Biopharma

Gene Editing Solutions with Off-the-Shelf GMP CRISPR/Cas9 Nucleases

Benefits of Integrated Small-Volume Manufacturing Capabilities

The Critical Role of Continuous Improvement in Parenteral Drug Manufacturing

A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways

Novavax Expands Large-Scale Global Manufacturing Capacity for COVID-19 Vaccine

AstraZeneca Collaborates with ArcherDX to Use Personalized Cancer Assays to Detect Minimal Residual Disease in Lung Cancer Trials

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

Montefiore-Einstein Scientists Lead Two Trials of Leronlimab for COVID-19

Specialized Know-How and Capacity to Support Demand for Oncolytic Viruses

M&A: Fundamental to Pharma Industry Growth

Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

Thermo Fisher Scientific and CSL Enter Strategic Partnership

Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility

Vetter Wins Axia Best Managed Companies Award

Procuring Equipment at the Speed of Business

Meeting the Growing Need for Complex Injectable Product Development and Manufacturing

Merck to Acquire Themis

FDA Provides Promised Transparency for Antibody Tests

IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics

Current Trends & Future Prospects in Outsourced Pharmaceutical Manufacturing

Roche's Highly Accurate Antibody Test for COVID-19 Goes Live at More than 20 Initial Lab Sites in the U.S.

AstraZeneca Advances Response to COVID-19 After Receiving First Commitments for Oxford’s Potential New Vaccine

ViiV Healthcare’s Injectable Formulation Dosed Every Two Months Shows Higher Efficacy than Daily Oral PrEP

Philips Launches HealthSuite Clinical Trial Accelerator

Phlow Corporation Awarded $354 Million HHS/ASPR/BARDA Contract to Manufacture Essential Medicines in Shortage

Apple and Google Launch Exposure Notification API to Support Public Health Agencies

Continuously Tracking Fear Response Could Improve Mental Health Treatment

HKBU Scientists Eliminate Drug Side Effects by Manipulating Molecular Chirality

High-Productivity Membrane Chromatography to Enable Next-Generation Purification of Monoclonal Antibodies

Impurity Identification in Small-Molecule APIs

An R&D Engine for Novel Immune Therapies

RNA Biomarkers for Early Lung Cancer Diagnosis

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests

Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

STI-1499, a Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability to Completely Inhibit In Vitro Virus Infection In Preclinical Studies

Concentrating on Core OSD & Sterile Capabilities for Assured Client Success

FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients

Abbot Receives FDA Authorization for COVID-19 Antibody Blood Test System

MyoKardia Announces Primary and All Secondary Endpoints Met in Phase 3 Clinical Trial for the Treatment of Obstructive Hypertrophic Cardiomyopathy

HKBU-led Research Team Develops Novel Anti-viral Targeted Drug for Nasopharyngeal Cancer Treatment

Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test

Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19

AstraZeneca Completes Recovery of Global Rights to Brazikumab from Allergan

USP Launches Trust Accelerated Program to Speed Development of COVID-19 Treatments and Vaccines

Accelerated Innovation Is the Key to the UK’s Post-Brexit Life Sciences Leadership

In Their 25th Year, That’s Nice Looks Forward to the Future of Healthcare

How is Arranta Bio Preparing to Face the Future of Healthcare?

How would you characterize the current landscape of M&A activity in the pharmaceutical/biopharmaceutical industry?

Yourway and Firma Clinical Research Collaborate to Administer Coordinated Supply Delivery for Home-Health Clinical Trial Visits

Trxade Group, Inc. Withdraws Its Previously Filed FDA Emergency Use Authorization for Rapid COVID-19 Testing Kit

Seaweed Extract Reduces Flu Severity

Enlivex Announces Initiation of Multi-Center Phase II Investigator-Initiated Clinical Trial of Allocetra in COVID-19 Patients

Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine

Integrating ADC Manufacturing for the Future

Farxiga Approved in the US for the Treatment of Heart Failure in Patients

FDA Approves GSK's Zejula

FDA Accepts for Priority Review Bristol Myers Squibb’s Application for CC-486 for Maintenance Treatment of Adult Patients in Remission with Acute Myeloid Leukemia

AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie's Acquisition of Allergan

PTC Therapeutics to Acquire Censa Pharmaceuticals

Novartis Announces FDA Approval of MET Inhibitor Tabrecta™ for Metastatic Non-Small Cell Lung Cancer with METex14

Angion Announces Publication of ANG-3777 Phase 2 Results in Scientific Journal

First Cell and Gene Therapy Manufacturing Center Located on a U.S. University Campus Is Named

The Future of the CDMO Market: The Art of the Possible

How is Federal Equipment Company Preparing to Face the Future of Healthcare?

How Close Is CRISPR to Eradicating Disease and Correcting Genetic Defects?

SEQENS Mobilizes its Innovation to Support the Unprecedented Research on COVID-19

Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer

Pharmaceutics International Selected as a Winner of Two GH&P Awards

Vir and Alnylam Identify RNAi Therapeutic Development Candidate Targeting SARS-CoV-2

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus

INTERPHEX Postponed Until 2021

Wyss-Designed Swabs Enter Human Trials for COVID-19

Iceland Provides a Picture of the Early Spread of COVID-19 in a Population with a Cohesive Public Health Response

Business Leadership: A Requirement for Successful M&A Outcomes

Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate

1 3

»